Papers

Peer-reviewed
Nov 15, 2017

Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.

Internal medicine (Tokyo, Japan)
  • Hideharu Hagiya
  • ,
  • Koji Miyawaki
  • ,
  • Norihisa Yamamoto
  • ,
  • Hisao Yoshida
  • ,
  • Akihiro Kitagawa
  • ,
  • Tadafumi Asaoka
  • ,
  • Hidetoshi Eguchi
  • ,
  • Yukihiro Akeda
  • ,
  • Kazunori Tomono

Volume
56
Number
22
First page
3103
Last page
3107
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.2169/internalmedicine.8774-16

Ceftriaxone is a widely used third-generation cephalosporin showing advantageous pharmacokinetic properties and a broad antimicrobial spectrum. We herein report a case of ceftriaxone-induced neurotoxicity in a 56-year-old man on hemodialysis. Seven days after initiating high-dose ceftriaxone, the patient developed impaired consciousness along with facial myoclonus and sporadic phonation. The symptoms clearly disappeared shortly after withdrawal of the drug. Ceftriaxone is considered a safe antibiotic for patients with renal insufficiency, since it is excreted via both haptic and renal pathways. Physicians should note that antibiotic-associated encephalopathy may develop in patients administered ceftriaxone, especially in those complicated with renal dysfunction.

Link information
DOI
https://doi.org/10.2169/internalmedicine.8774-16
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/28943562
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725869
ID information
  • DOI : 10.2169/internalmedicine.8774-16
  • ISSN : 0918-2918
  • Pubmed ID : 28943562
  • Pubmed Central ID : PMC5725869

Export
BibTeX RIS